212 related articles for article (PubMed ID: 31586988)
21. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
He M; Hu F
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
[TBL] [Abstract][Full Text] [Related]
22. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
23. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
24. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide profiling of alternative splicing in glioblastoma and their clinical value.
Li Y; Guo D
BMC Cancer; 2021 Aug; 21(1):958. PubMed ID: 34445990
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide profiling of chemoradiation‑induced changes in alternative splicing in colon cancer cells.
Xiong W; Gao D; Li Y; Liu X; Dai P; Qin J; Wang G; Li K; Bai H; Li W
Oncol Rep; 2016 Oct; 36(4):2142-50. PubMed ID: 27573869
[TBL] [Abstract][Full Text] [Related]
27. Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.
Zong Z; Li H; Yi C; Ying H; Zhu Z; Wang H
Front Oncol; 2018; 8():537. PubMed ID: 30524964
[No Abstract] [Full Text] [Related]
28. Identification of alternative splicing and RNA-binding proteins involved in myocardial ischemia-reperfusion injury.
Feng L; Guo M; Jin C
Genome; 2023 Oct; 66(10):261-268. PubMed ID: 37466303
[TBL] [Abstract][Full Text] [Related]
29. Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer.
AZhaTi B; Wu G; Zhan H; Liang W; Song Z; Lu L; Xie Q
World J Surg Oncol; 2022 Jul; 20(1):231. PubMed ID: 35820925
[TBL] [Abstract][Full Text] [Related]
30. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
31. Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma.
Zhang YF; Wang YX; Zhang N; Lin ZH; Wang LR; Feng Y; Pan Q; Wang L
Bioengineered; 2021 Dec; 12(1):1202-1211. PubMed ID: 33830865
[TBL] [Abstract][Full Text] [Related]
32. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.
Thorsen K; Sørensen KD; Brems-Eskildsen AS; Modin C; Gaustadnes M; Hein AM; Kruhøffer M; Laurberg S; Borre M; Wang K; Brunak S; Krainer AR; Tørring N; Dyrskjøt L; Andersen CL; Orntoft TF
Mol Cell Proteomics; 2008 Jul; 7(7):1214-24. PubMed ID: 18353764
[TBL] [Abstract][Full Text] [Related]
33. Role of alternative splicing signatures in the prognosis of glioblastoma.
Xie ZC; Wu HY; Dang YW; Chen G
Cancer Med; 2019 Dec; 8(18):7623-7636. PubMed ID: 31674730
[TBL] [Abstract][Full Text] [Related]
34. Identification of Key Prognostic Alternative Splicing Events of Costimulatory Molecule-Related Genes in Colon Cancer.
Ding H; Shi H; Chen W; Liu Z; Yang Z; Li X; Qiu Z; Zhuo H
Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 37957898
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
[TBL] [Abstract][Full Text] [Related]
36. Identification of Prognostic alternative splicing signatures and their clinical significance in uveal melanoma.
Zhou W; Fei P; Li J
Exp Eye Res; 2021 Aug; 209():108666. PubMed ID: 34129849
[TBL] [Abstract][Full Text] [Related]
37. Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancer.
Zhang Z; Feng Q; Jia C; Zheng P; Lv Y; Mao Y; Xu Y; He G; Xu J
Genomics; 2020 Nov; 112(6):4032-4040. PubMed ID: 32645524
[TBL] [Abstract][Full Text] [Related]
38. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
40. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
Xing L; Zhang X; Tong D
DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
